alpha-Actinin 1 Antibody (1D10) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59465B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # 1D10
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human alpha-Actinin 1 (1-249aa) purified from E. coli
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Applications for alpha-Actinin 1 Antibody (1D10) [Biotin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: alpha Actinin 1
Long Name
Actinin alpha 1
Alternate Names
ACTN1, alpha-Actinin 1, alphaActinin 1, BDPLT15
Gene Symbol
ACTN1
Additional alpha Actinin 1 Products
Product Documents for alpha-Actinin 1 Antibody (1D10) [Biotin]
Product Specific Notices for alpha-Actinin 1 Antibody (1D10) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...